Quest Diagnostics Ranks No. 1 in Industry Category on FORTUNE's World's Most
Admired Companies List
MADISON, N.J., March 4, 2013
MADISON, N.J., March 4, 2013 /PRNewswire/ -- Quest Diagnostics (NYSE:DGX), the
world's leading provider of diagnostic information services, today announced
that that it has been recognized in FORTUNE magazine's "World's Most Admired
Companies" list as the No. 1 company in the Health Care industry category of
"Pharmacy and Other Services."
"We are proud that Quest Diagnostics has rejoined FORTUNE's World's Most
Admired Companies as the leader in our category," said Steve Rusckowski,
President and CEO. "Thisaccomplishment reflects the passion of our employees,
who every day empower better health with diagnostic insights forpeople
throughout the communities we serve."
FORTUNE's list of Most Admired Companies is based on surveys of thousands of
executives, directors and securities analysts based on nine criteria:
innovation, people management, use of corporate assets, quality of management;
social responsibility; financial soundness, long-term investment, quality of
products and services, and global competitiveness.
The ranking for Quest Diagnostics may be found online at
About Quest Diagnostics
Quest Diagnostics is the world's leading provider of diagnostic information
services that patients and doctors need to make better healthcare decisions.
The company offers the broadest access to diagnostic information services
through its network of laboratories and patient service centers, and provides
interpretive consultation through its extensive medical and scientific staff.
Quest Diagnostics is a pioneer in developing innovative diagnostic tests and
advanced healthcare information technology solutions that help improve patient
care. Additional company information is available at QuestDiagnostics.com.
Follow us at Facebook.com/QuestDiagnostics and Twitter.com/QuestDX.
Quest, Quest Diagnostics, and all associated Quest Diagnostics registered or
unregistered trademarks are the property of Quest Diagnostics. All third-party
marks are the property of their respective owners.
Quest Diagnostics Contacts:
Dan Haemmerle (Investors): 973-520-2900
Wendy Bost (Media): 973-520-2800
SOURCE Quest Diagnostics
Press spacebar to pause and continue. Press esc to stop.